CROI 2025 Abstract eBook

Abstract eBook

Search Term Index

Public health 871, 909, 1158, 1327, 1328 Pulmonary 375, 914 Pulmonary tuberculosis 950, 958 PWID 183, 1316 Pyroptosis 364 Qualitative research 1352 Quality assurance 568 Quality of life 887, 889, 949, 1325 Quantification 558, 561, 789 Queer 1118 Race/ethnicity 860, 1111, 1116 Racial Segregation 1120, 1226 Rakai 1122 Randomized clinical trial 107, 114, 143, 204A, 204B, 506, 536, 658, 659, 663, 692, 720, 862, 916 Rapid test 1188 Reactivation 770 Reactogenicity 807 Readmission 815 Real time PCR 1196, 1197 Real world data 674, 676, 696, 714, 739, 1011, 1200, 1338, 1359, 1361 Rebound virus 103 Recency 1006, 1188, 1194 Recency testing 1108, 1188, 1194 Recent infection 1108, 1125, 1126, 1188 Recombinant 474, 482 Reengagement 188, 1328, 1330 Registry 697 Regulation 325 Reinfection 750, 1092 Rejection 856 Relinkage 1338 Remdesivir 714, 715, 716, 1097 Remission 1033 Renal 858 Renal function 660 Renal outcomes 855, 859, 1361 Renal tubular disease 332 Repertoire 607, 856 Reproductive aging 543, 1106 Reproductive health 1244, 1250, 1252, 1258 Reservoirs 169, 501 Resilience 1289 Resistance 197, 732 Resistance-associated mutation 156, 716, 734 Resistance mechanisms 155, 727 Resistance testing 744 Resource limited setting 743 Restriction factor 327, 328 Retention in care 185, 187, 188, 669, 1059, 1081, 1088, 1301, 1307, 1324, 1336 Retrospective cohort 671, 704, 1076, 1298 Retrovirus 398 Reverse transcription 317 Rhesus macaques 139, 339, 391, 397, 416, 431, 459, 1040, 1233 Rifampicin 645, 646, 647, 951, 969 Rifampin 969 Rifapentine 116, 958 RIG-I 141 Rilpivirine 655, 677, 678, 679, 680, 681, 683, 684, 687, 731, 1046 Risk 953 Randomized trial 807, 991 Rapid diagnostic test 1247

Sarcopenia 871, 875 SARS-CoV-2 158, 200, 309, 310, 312, 331, 332, 336, 338, 339, 364, 472, 473, 474, 475, 476, 477, 657, 712, 713, 716, 719, 933, 940, 941, 945 SARS-CoV-2 3C-like protease inhibitor 200, 711, 713 SARS-CoV-2 vaccination 473, 476, 480, 1251 SARS-CoV-2 vaccine in PWH 518 SARS-CoV-2 variants 158, 311, 313, 332, 474, 476, 479 Scale-up 1296 Screening 160, 633, 786, 806, 871, 909, 976, 989, 1185, 1330 Second-line 123, 669, 952 Self-testing 1178 Senegal 767 Senescence 873, 876 Sensitivity 1185 Sepsis 912 Sequencing 404 Seroconversion 666, 1231 Serodiscordant couple 118, 1141, 1181 Serology 441, 954, 1038, 1191 Seroprevalence 751 Serostatus 303 Severe disease 143 Severity 853 Sex 678, 1100 Sex difference 308, 370, 371, 470, 519, 566, 572, 824, 882, 988, 1150 Sexual and gender minority 1199, 1279, 1302, 1353 Sexually transmitted infection 162, 164, 436, 982, 1090, 1144, 1239, 1240, 1242, 1243, 1266, 1268, 1271, 1272, 1273, 1274, 1278, 1279, 1281, 1284, 1286, 1287, 1342, 1358 SHIV 148, 318, 416, 451, 515, 1233, 1238 Shock 1289 Shock and kill 530, 576 Short-chain fatty acids (SCFAs) 827 Sialidase inhibitor 454 Silencing 574 Simulation modeling 641, 782, 1290, 1292, 1295, 1296 Single-cell 582, 607 Single-cell transcriptomics 142, 309, 416, 467, 469, 518, 524, 1039 Single cell 137, 359, 422, 471, 586 Single copy assay 628 Single genome sequencing 306, 346, 413 Single nucleus 606, 607 SiRNA 158 SIV 103, 106, 139, 147, 328, 330, 338, 339, 394, 397, 401, 449, 502, 520 Skin 1197 Sleep 617, 987 Sleep apnea 635, 904 Small molecule 504, 528, 533, 712 SNP 371 Social determinant 1006, 1082, 1100, 1101, 1117 Social determinants of health 1115 Social inequality 1082 Social needs 1171 Social network 1083, 1349 Sociodemographic 835, 1336 Socioeconomic Disparities 1348 SOSIPs 1040 South Africa 130, 521, 679, 743, 744, 809, 987, 1234, 1299, 1343, 1357 Sexual behavior 1093, 1137 Sexual health 1260, 1314 Sexual partner 1139, 1141 Sexual risk behavior 1140, 1225, 1273 Sexual transmission 1154, 1241, 1275

STI diagnosis and treatment 1265, 1286 STI testing 1216, 1247, 1255, 1286 Stigma 887, 950, 1117, 1308, 1345 Stool microbiota 604 Strategic plan 1184 Stratified medicine 565 Stroke 829, 844 Structure 726 Study design 644 Stunting 1022 Sub-Saharan Africa 126, 143, 186, 331, 806, 978, 996, 1132, 1141, 1158, 1312, 1317, 1354 Subcutaneous 203 Subgroup 865 Substance use 888, 1083, 1102, 1105, 1146, 1259 Substance use disorder 754 Substance use treatment 1259 Subtype 733, 1158 Subtype B 150

TLD 745, 747, 987, 1000 TLR7 105, 470, 1043 Tobacco 968

Torquetenovirus 480 Total HIV-1 DNA 672 Toxicity 1004 Toxoplasmosis 979 Traditional healers 1317 Transaminase 667 Transcription 349, 495, 511, 525, 560, 587 Transcriptome 379, 391, 549, 953 Transcriptomic 111, 340, 455, 631 Transfer 186 Transfusion 1186 Transgender individuals 164, 913, 1353 Transgender men 196 Transgender women 409, 1108, 1109, 1110, 1204, 1350 Transition 995 Transmission 115, 962 Transmission cluster 300, 1127, 1155 Transmitted drug resistance 115, 733 Transmitted founder 326 Transplant 532 Transplantation 1168 Treatment 125, 1097 Treatment adherence 186, 1058, 1060, 1082, 1311, 1318 Treatment as prevention 1084, 1207, 1278 Treatment cascade 1132 Treatment experienced 1133 Treatment failure 681 Treatment interruption 403, 1034 Treatment naive 152, 153, 735, 891 Treatment outcomes 687, 1363 Treatment simplification 659 Treg 518 Trend 128, 1164 Treponema pallidum 982, 1242, 1245 Triglyceride 826 Tuberculosis 114, 115, 347, 646, 647, 700, 948, 953, 956, 957, 959, 960, 961, 962, 964, 965, 969, 970, 980, 989 Tumor microenvironment 787 Type 2 diabetes 905 Type I interferon 141, 333, 392, 470 Uganda 131, 177, 943, 1122, 1136 Ultrasound 839 UNAIDS 95-95-95 goals 184, 1151 Undetectable equals untransmittable 303 Undocumented immigrant 693 Unintended pregnancy 1252, 1254 TRIM21 325 Tropism 515 Tryptophan 837

Subtype C 150, 521 Suicide 1064, 1302 Superinfection 854 Surveillance 923 Surveillance data 1011, 1102, 1338 Survey 1205, 1256 Survival 125, 816 Survival analysis 853, 1081, 1160 Survivor 924, 1171 SVR 750, 778 Switching 665, 897, 1203

Symptom 924, 925 Symptomology 1187 Synaptic 595

Syphilis 160, 161, 982, 1090, 1101, 1189, 1239, 1240, 1241, 1242, 1243, 1244, 1245, 1246, 1247, 1248, 1249, 1267, 1271, 1272, 1280, 1282 Systemic inflammation 355, 385, 388, 427, 638, 831, 1071 T-cell response 144, 479, 494, 533 T cell activation 335, 933 T cell immunity 407, 442 T cell phenotype 409 T cell receptor 104 T cell response 394, 425, 428, 441, 478 T cell subsets 469, 901 T cells 505 T regulatory cell 469 TAF 651, 653, 660 Tanzania 889, 1205, 1313 Targeted therapy 503 Targeting 426 TB preventative therapy 116, 971 TCF-1 502 TCR 471, 501 TCR repertoire 142, 145, 404, 608, 929 TDF/FTC 1361 Tecovirimat 159 Telehealth 190 TelePrEP 1206, 1223 Telomere length 867, 876, 1026 Temporal trends 798, 1111, 1210, 1267, 1350 Tenofovir 710, 771, 775, 900, 1213, 1332 Tenofovir alafenamide 123, 194, 646, 647, 667, 771, 823, 826, 892, 893 Tenofovir diphosphate 157, 646 Tenofovir disoproxil fumarate 117, 157, 667, 771, 893, 1054 Teropavimab 151 Testing 1120 Tfh 583 TFV-DP 650, 651, 1010 TGF-Beta 427, 498 Thailand 171, 622, 885, 1176, 1346 Therapeutic vaccine 425, 1040 TIGIT 410 Time-to-rebound 149 Timing 715 Timing of therapy 714 Tissue 520 Tissue pharmacokinetics 657 Tissue resident cells 101 Tissue resident memory T cells 584

Search Term Index

United States 943, 981, 1359 Universal test and treat 1130 Unmet contraceptive need 1253

Unmet Needs 1226 Uptake 162, 1337

Urine drug detection 1332 Urine tenofovir 1212, 1214 V2 loop 150 V3 region 304

Vaccination 112, 1067 Vaccination status 1067 Vaccine 112, 482, 483 Vaccine coverage 1210 Vaccine response 433, 1095 Vaginal 1283 Vaginal ring 1256 Validation 789, 1185 Variability 655 Variant 314 Vascular 375, 1071 Vertical transmission 161, 1005, 1011, 1013, 1014, 1030, 1249, 1253

Risk assessment 833, 1125 Risk factors 809, 1175, 1199 Risk score 818, 851, 1187 Ritonavir 1018 rLNP 534 RNA-protein interaction 324 RNA seq 359, 609 RNA sequencing 321, 517 RNA splicing 100, 348

RNA transcript 627 RPV-LA 1016, 1362 RSV 309 Rural 917 Rural Uganda 619 Ryan White HIV/AIDS program 1078 Safety 426, 428, 488 Saliva 936 Salvage 698

Southern Africa 493, 1142 Spatial analysis 137, 787 Specificity 1185 SpFN 473 Standard regimen 1218 Statins 178, 624, 851, 852, 877 STD 1276

Veteran 741 Violence 992 Viral blip 1175 Viral control 486, 563 Viral decay 935

Viral diversity 346, 725, 740 Viral dynamics modeling 1034 Viral entry 307

Steatosis 762, 811 Stemness 106, 146

CROI 2025 490